ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Raises Concerns About China-Developed Drugs FirstWordPharma
February 10, 2022A negative FDA staff report for Eli Lilly and partner Innovent Biologics' anti-PD-1 cancer drug sintilimab could slow the plans of large Western drugmakers such as Novartis looking to sell Chinese-tested medicines...
Pharma Sources Insight January 2025
